VTRS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VTRS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Viatris's share price for the quarter that ended in Dec. 2024 was $12.45. Viatris's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 1,194 Mil. Therefore, Viatris's market cap for the quarter that ended in Dec. 2024 was $14,861 Mil.
Viatris's quarterly market cap increased from Jun. 2024 ($12,684 Mil) to Sep. 2024 ($13,857 Mil) and increased from Sep. 2024 ($13,857 Mil) to Dec. 2024 ($14,861 Mil).
Viatris's annual market cap declined from Dec. 2022 ($13,510 Mil) to Dec. 2023 ($13,004 Mil) but then increased from Dec. 2023 ($13,004 Mil) to Dec. 2024 ($14,861 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Viatris's Enterprise Value for Today is $24,061 Mil.
The historical data trend for Viatris's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viatris Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Market Cap | Get a 7-Day Free Trial |
![]() |
![]() |
22,617.23 | 16,364.63 | 13,509.52 | 13,004.18 | 14,860.92 |
Viatris Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Market Cap | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
13,004.18 | 14,213.46 | 12,684.45 | 13,857.48 | 14,860.92 |
For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Viatris's Market Cap distribution charts can be found below:
* The bar in red indicates where Viatris's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Viatris's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
Market Cap (A: Dec. 2024 ) | = | Share Price (A: Dec. 2024 ) | * | Shares Outstanding (EOP) (A: Dec. 2024 ) |
= | $12.45 | * | 1193.648 | |
= | $14,861 |
Viatris's Market Cap for the quarter that ended in Dec. 2024 is calculated as
Market Cap (Q: Dec. 2024 ) | = | Share Price (Q: Dec. 2024 ) | * | Shares Outstanding (EOP) (Q: Dec. 2024 ) |
= | $12.45 | * | 1193.648 | |
= | $14,861 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viatris (NAS:VTRS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Thank you for viewing the detailed overview of Viatris's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul Campbell | officer: See Remarks | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
Rajiv Malik | director, officer: President | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
Brian Roman | officer: Global General Counsel | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Anthony Mauro | officer: See Remarks | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
Dillon Joellen Lyons | director | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HARTFORDSHIRE X0 AL 109UL |
Xiangyang (sean) Ni | officer: President, Greater China | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Andrew Cuneo | officer: See Remarks | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Harry Korman | director | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
Leo Frans Groothuis | director | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Scott Andrew Smith | director | C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
Van Der Meer Mohr Pauline | director | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Menassie Taddese | officer: See Remarks | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Robert J Coury | director, officer: Executive Chairman | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
W Don Cornwell | director |
From GuruFocus
By PRNewswire • 01-07-2025
By GuruFocus News • 02-03-2025
By GuruFocus News • 11-22-2024
By PRNewswire • 10-29-2024
By ACCESSWIRE • 10-15-2024
By ACCESSWIRE • 02-19-2025
By Shanti Putri • 10-15-2024
By GuruFocus News • 10-09-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 01-07-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.